A message from Dr. William Beecroft
We’re expanding our CLIMB opioid treatment model to select Blue Cross members
Traditional methods for treating opioid use disorder sometimes work, but 36 percent* of patients relapse. Of those who do relapse, 72 percent* do so multiple times. Read more.
A message from Dr. Duane DiFranco
Here’s an overview of Blue Cross’ efforts to address opioid epidemic
More than 2,600 Michigan residents died in 2017 from drug overdoses, exceeding the number of traffic and firearm fatalities reported that year. As the opioid epidemic continues to capture the attention of public health officials and decision-makers across the country, Blue Cross Blue Shield of Michigan and Blue Care Network are continuing efforts to address the issue through public awareness, collaboration and improvements to clinical care delivery. Read more.
A roundup of recent news and information
Prior authorization to be required for high opioid dosages
Starting Feb. 1, 2019, Blue Cross and BCN will require prior authorization the first time a member’s opioid dosage exceeds 90 morphine milligram equivalents per day. This change affects commercial members only and doesn’t apply to members with an oncology diagnosis or terminal illness, or those with Medicare plans. For complete details, see the January Record article. Read more.
|
